| Up
2006P-0311:
Investigate and Take Regulatory Action to Protect Surgical Patients
from a Potential Significant Safety risk in Connection with Propofol
Injectable Emulsion Marketed by Bedford Laboratories
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
| |
CP1 |
|
08/07/2006
|
|
08/07/2006
|
|
Private Industry
|
|
Foley &
Lardner LLP |
|
|
|
|
|
|
|
Table
of Contents |
|
|
|
| |
Signature: |
|
David L. Rosen, B.S. Pharm,
J.D. |
|
| |
| |
ACK1 |
|
08/07/2006
|
|
08/07/2006
|
|
Federal Government |
|
FDA/DDM to Foley
& Lardner LLP |
|
|
|
|
|
|
|
pdf |
|
|
|
| |
|
|
Signature: |
|
Lyle D. Jaffe |
|
Top | Up
Page last updated
August 25, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
